GO Term | Evidence Code | PMID |
---|---|---|
negative regulation of G1/S transition of mitotic cell cycle | ||
metanephric smooth muscle tissue development | ||
aorta development | ||
negative regulation of cell population proliferation |
|
|
negative regulation of ryanodine-sensitive calcium-release channel activity |
GO Term | Evidence Code | PMID |
---|---|---|
mitotic spindle | ||
cytoplasm | ||
cell-cell junction | ||
basal plasma membrane | ||
cation channel complex |
GO Term | Evidence Code | PMID |
---|---|---|
cytoskeletal protein binding | ||
ATPase binding | ||
monoatomic cation channel activity | ||
calcium channel activity | ||
muscle alpha-actinin binding |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:4676 | uremia | |
DOID:4766 | embryoma | |
DOID:0050424 | familial adenomatous polyposis | |
DOID:0050156 | idiopathic pulmonary fibrosis | |
DOID:0050646 | distal arthrogryposis | |
DOID:0050770 | polycystic liver disease | |
DOID:0050771 | pheochromocytoma | |
DOID:0050778 | Meckel syndrome | |
DOID:0050820 | atrioventricular block | |
DOID:0050997 | cerebellar ataxia, mental retardation and dysequlibrium syndrome |
HPO ID | HPO Term |
---|---|
HP:0003259 | Elevated circulating creatinine concentration |
HP:0003596 | Middle age onset |
HP:0003621 | Juvenile onset |
HP:0003676 | Progressive |
HP:0003774 | Stage 5 chronic kidney disease |
HP:0003829 | Typified by incomplete penetrance |
HP:0004944 | Dilatation of the cerebral artery |
HP:0005562 | Multiple renal cysts |
HP:0006254 | Elevated circulating alpha-fetoprotein concentration |
HP:0006557 | Polycystic liver disease |
Disease ID | Disease Name |
---|---|
ORPHA:730 |
|
OMIM:613095 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
178424 | WB:WBGene00004035 | ||
34651 | FB:FBgn0041195 | ||
102353493 | LATCH05511 | ||
432387 | ZFIN:ZDB-GENE-040827-4 | DANRE17787 | |
103043751 | ASTMX17308 | ||
108262951 | ICTPU26330 | ||
113591982 | ELEEL47778 | ||
106602324 | SALSA118029 | ||
115191757 | SALTR28967 | ||
115202269 | SALTR16984 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024